DS-DP Interdependency in RNA-LNP: Strengthening Platform Maturity Through Deeper Understanding

1:30 pm - Thursday 1st October 2026

  • Developing scalable, semi-automated workflows to streamline mRNA and LNP production from plasmid DNA through to encapsulated product for rapid preclinical evaluation
  • Leveraging liquid handling systems and high-throughput screening platforms to accelerate formulation optimization while maintaining material quality suitable for in vivo studies
  • Sharing lessons learned from translating mRNA and LNP processes across bench-scale, GMP manufacturing, and miniaturized automated screening systems

Speakers:

Head of DP Platform and Early Clinical Development
Sanofi